SirtAct (CAY10591)

SirtAct (CAY10591)

Catalog Number:
I001528179REA
Mfr. No.:
EI-SRT-005
Price:
$306
  • Size:
    5 mg
    Quantity:
    Add to Cart:
      • Overview
        • 2-?Amino-?N-?cyclopentyl-?1-?(3-?methoxypropyl)-?1H-?pyrrolo[2,?3-?b]quinoxaline-?3-?carboxamide; CAY10591

          SirtAct is a Sirt1 activator (233% at 10 mM using the BIOMOL Fluor-de-Lys assay) Suppresses TNFa release from THP-1 cells and stimulates adipogenesis in 3T3L1 cells. SIRT1 stimulation by SirtAct leads to decreased tissue factor mediated thrombogenicity in mice. Inhibits NFkB activation and reduces inflammatory cytokine production in lamina propria mononuclear cells from IBD patients. Prevents and cures experimental colitis in a mouse model.

          Please contact us at for specific academic pricing.

      • Properties
        • Molecular Formula
          C20H25N5O2
          Molecular Weight
          MW=367.4
          Appearance
          Olive green powder
          Solubility
          Solubilization: May be dissolved in DMSO (50 mg/ml); or ethanol (20 mg/ml, warm)
          Storage
          Store desiccated as supplied at -20°C for up to 2 years. Store solutions at -20°C for up to 3 months.

          * For Research Use Only.

      • Applications
        • Application
          Epigenetic Inhibitors

    Note: If you don't receive our verification email, do the following:

    Copyright © Amerigo Scientific. All rights reserved.